Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 5, May 2026

    May 13, 2026

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026
      Bank of England

      Prudential Regulation Authority Publishes New Funded Reinsurance Regulations

      April 29, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      CHIP Mortgage Trust Issues C$200m of Medium-Term Notes

      April 29, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Still Plenty of Capacity for Growth in Robust US PRT Market

    Longevity and Mortality Risk Transfer January 10, 2024By Aaron Woolner
    Share
    Twitter LinkedIn Email

    The US pension risk transfer (PRT) market saw a record-breaking first half of 2023 with deals worth $22.5bn recorded, according to data from Legal & General Retirement America (LGRA), but full year numbers are likely to be lower than the all-time high recorded in 2022.  

    Despite a number of deals taking place in the third quarter, including a plan termination by aerospace firm AAR Corp, and partial buy-outs by Owens Corning and ATI Inc, there were none on the scale of the record breaking $16bn PRT conducted by IBM during the same period 12 months earlier. 

    LGRA’s November PRT Monitor said that a total of $10bn worth of deals were struck in the third quarter of 2023 and it estimated that full year volumes would be about $45bn, below the record $51.9bn seen in 2022. 

    According to Jake Pringle, Houston-based Principal and Consulting Actuary at Milliman, there was no slackening of demand in the US PRT sector in the second half and that instead the busy first half meant some insurers reached their capacity limits as the year progressed.  

    “Because the second quarter of 2023 was so busy we started to see insurers reach capacity by the end of the year because a lot of carriers were probably ahead of schedule on the amount of business they wanted to write. 

    In the third and fourth quarters, insurers started to be more selective and say: ‘We’d like to bid on this one but we’re at capacity and don’t have the ability to onboard this particular plan’”, Pringle says.  

    Pringle says that despite these capacity constraints the sheer competitiveness of the US PRT market meant pricing remained competitive in the second half of 2023.  

    “With all the entrants that have come into the market over the last five years we know going into a PRT transaction, there will be a number of insurers which meet the plan sponsor’s criteria. 

    But even in those cases, where we were seeing fewer insurers, it was still possible to get competitive pricing on PRT projects,” says Pringle.  

    Sheena McEwen, Head of Distribution at LGRA, agreed with Pringle that US PRT deals are priced at a competitive level and she says that more entrants to the market are likely.  

    “PRT transactions are priced very attractively. Often, sponsors can get pricing which is very close to the values that they’re holding on their balance sheets, and they may not even need to make additional contributions to complete a deal. 

    “There’s now over 20 insurers active in the US PRT sector, which is a lot. And I expect more to come on to the market. Exactly how many and when is unclear but the flow of new entrants is likely to continue,” says McEwen.  

    The numbers and names of insurers active in the US PRT sector may evolve in the near term but it is almost certain to remain focused on partial, or full, buy-outs.  

    According to Milliman’s November Global PRT Market Outlook, 93% of US transactions in 2022 by premium value were some form of buy-out. 

    And while US insurer Prudential Financial took the largest chunk of a $14.2bn longevity risk transfer from Dutch financial services firm NN Group in December, McEwen doesn’t expect to see a similar market emerge in the US itself.  

    “The US is unlikely to see the widespread uptake of alternative forms of PRT such as longevity swaps. There is a different dynamic in the market in terms of the risks that plan sponsors are looking to manage versus, say, the UK,” she says.  

    The main reason for the US PRT market’s buy-out focus is that other forms of risk transfer won’t reduce a plan sponsor’s Pension Benefit Guaranty Corporation (PBGC) premiums.  

    In 2024 these are set to increase again to $101 per head, more than double the 2014 figure of $49.   

    “PBGC premiums will continue to be a major driver of the US PRT market. If a sponsor completes a full buy-out it means it no longer has to pay these premiums, as well as removing a source of volatility from its balance sheet. 

    A longevity swap, for example, would not bring relief from making these statutory contributions,” McEwen says.  

    Another reason is that US pensions are not typically indexed to inflation, with Milliman’s Pringle estimating that only about 25% of private sector schemes contain this benefit. 

    This contrasts with pension schemes in the UK and the Netherlands, which are typically indexed to inflation, making longevity risk transfers more attractive to European plan sponsors.  

    “Because UK annuities are indexed it means there is a lot more tail risk from people living longer than in the US, which is potentially why there’s more value in having a market for longevity swaps in the UK and other regions. 

    That means when a plan sponsor is doing a cost benefit analysis of a PRT transaction in the US, it can be much more compelling to conduct a full buyout than any other kind of partial de-risking products like longevity swaps,” says McEwen.  

    Longevity swaps may be off the menu but McEwen is confident that the US PRT market will continue to see a robust level of activity this year. 

    “It doesn’t look like the US PRT market will slow down in 2024. There’s over $3trn in private sector DB assets out there. And only one or two per cent of it gets annuitized with insurers on an annual basis.  

    “There’s potential for significant annual market growth, it’s very difficult to predict exactly how that’s going to look, even just for next year, but there’s no sign that it’s going to slow down. I can certainly say that with a high level of confidence,” says McEwen.  

    Milliman’s Pringle agrees, saying that despite the slight dip in US interest rates in December macro factors will continue to boost plan sponsor’s appetite for PRT deals.  

    “There are a lot of plans in our pipeline that are looking to do a transaction at some point in 2024,” he says.  

    Volatility in the UK government bond (gilt) market in October 2022 resulted in an increased interest in PRT from funds with an LDI strategy in 2023, but Pringle says the US market is different.  

    “For plans which have executed an LDI strategy, movements in interest rates will have a minimal impact on their decision to complete a pension risk transfer. But plans which don’t have an LDI strategy in place will need to be more opportunistic in terms of how their assets are moving in relation to interest rates,” he added. 

    Pringle says that however interest rates move over the next 12 months, the continuing level of demand from plan sponsors for PRT deals and the capacity restraints experienced by some insurers in the second half of 2023 means there is room for more firms to enter the market.  

    “What was interesting to me was just how quickly some of the insurers reached capacity in 2023. I’ll be curious to see if that happens again in 2024.   

    “There was certainly room for more players in 2023, and if an insurer is on the cusp of being able to enter the market there are plenty of opportunities for them to win some business.”

    2024 - January Longevity Risk Pension Risk Transfer Volume 3 Issue 1 - January 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026By Mark McCord

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026By Greg Winterton

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble
    Just Group

    Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

    May 11, 2026By LMI Newsdesk
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.